Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells. - Wikidata - thesis-toulmin - TriplyDB

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.

http://www.wikidata.org/entity/Q30442808

about

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor Structural insights into the editing of germ-line-encoded interactions between T-cell receptor and MHC class II by Vα CDR3 Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells.Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors Human tumor antigens for cancer vaccine development.Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis.Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.Immunologic approaches to antigen discovery for cancer vaccines.TCR recognition of peptide/MHC class II complexes and superantigens Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".Over-expression of the testis-specific gene TSGA10 in cancers and its immunogenicity.Progress in the development of immunotherapy for the treatment of patients with cancer.Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?Enhancing antitumor immune responses: intracellular peptide delivery and identification of MHC class II-restricted tumor antigens.Multiple pathways to tumor immunity and concomitant autoimmunity.The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach.Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity.CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma.The development of a novel cancer immunotherapeutic platform using tumor-targeting mesenchymal stem cells and a protein vaccine Identification of human tumor antigens and its implications for diagnosis and treatment of cancer.Inducing autoimmune disease to treat cancer.Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis.Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer.Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules.Vaccination: role in metastatic melanoma.Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.Cancer immunotherapy targeting neoantigens.Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors.Enhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.

P2860

Q24604091-964B87B1-78C2-4C00-AC88-589D2197B53A Q27643966-616F1063-AC54-478B-BDAE-95D214A29DA9 Q28273830-4C4B63C1-CB58-4513-AA7A-E0D8B327385B Q30437344-6635E36D-4DF2-4A91-9E7D-8A1063C8E086 Q30444065-322B02C0-62BD-4C4B-B281-356CFF974B4E Q30454278-80A44625-214C-4A7D-9B3D-F5514D04A687 Q30621114-AA61ABA5-3C42-4B34-A56C-DD25A2F5C364 Q30859024-BB94E859-10A2-44D9-8F52-7CDD96EB11FE Q33222048-0791202A-3D38-43C1-92E1-E63872CACA7B Q33302672-937759CF-A4C3-4490-B3EE-41C28D2A2DB9 Q33606161-0BF9B83D-2E2B-4250-932F-B5B600B81BBF Q33776127-F8A549F8-9F9D-4185-9C18-75B859CC54C7 Q33967532-DD214E86-6DB5-42E1-B4E7-C45DA56E4313 Q34012255-DB8E76EC-07F1-408A-9AE0-621D17191B46 Q34074742-5B34C09C-A5B9-44C1-B197-2EE8E3857F67 Q34171867-8FE41F97-F403-489B-B118-1F22FA761F02 Q34276512-CC5A2DC1-8770-4016-B6D8-A175DA9D7047 Q34316228-AEB4861D-A72E-4226-BC40-3B88176C9D4B Q34570245-140282F9-BE25-4E20-876F-AFD912843029 Q34669820-1972462F-FA4F-498D-A2B3-AC4BD8330DA1 Q35005930-9A806996-AA55-447B-9D0B-E2CC29EC90A1 Q35005947-C441043C-31D5-41CE-BDDA-5979067F38AB Q35049933-53095C8D-AC4E-4CF4-A86C-B3305EDB986D Q35139240-B18F4600-09E3-4608-96C5-E5267167C681 Q35146595-19B5623D-E886-4016-A7F5-007F12402A5A Q35558644-FB51A0CD-9469-49B7-995F-B069135527AE Q35623444-7884DBC2-A276-4979-94F3-6E05F1D86C76 Q35927479-24E1A6A7-92BF-464F-92E5-FB016D48F664 Q35976297-665644E4-4B2C-4C5E-8C28-2284E27FC6D8 Q36369709-DDD5F10C-D756-44DF-A6AC-2626EEBC0B95 Q36369960-15823EBE-577B-4B9C-A739-DD5FDCE5C444 Q36382255-81598DB2-1CCF-4894-AFD0-97244F7B772D Q36456716-97015426-2521-48AE-B784-03DEB9C2417F Q36456744-78EF8EDF-28BA-4DD4-AAD6-F70CEE6DE3D5 Q36573868-81BDA070-222B-4B28-8A9A-C241A08C9C44 Q36696205-561CBA47-508C-41B1-A1E6-2636243E7F8A Q36871710-B3834DB3-D9F4-41A8-9E08-A1B5D946FC00 Q36889067-3D2141AC-8306-4BDE-B7BF-FF9AA1C268BF Q36976664-3FA083B1-FDF8-4F4F-9A53-17A02037BDE3 Q37139813-35AC86D5-1413-4311-BD2C-E44B97A1AFEA

P2860

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.

http://www.wikidata.org/entity/Q30442808

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Biochemical identification of ...... recognized by CD4(+) T cells.

@ast

Biochemical identification of ...... recognized by CD4(+) T cells.

@en

type

label

Biochemical identification of ...... recognized by CD4(+) T cells.

@ast

Biochemical identification of ...... recognized by CD4(+) T cells.

@en

prefLabel

Biochemical identification of ...... recognized by CD4(+) T cells.

@ast

Biochemical identification of ...... recognized by CD4(+) T cells.

@en

P1433

Q30442808-120A5B6D-E628-4C8E-AAE8-EE5180C781EC

P1476

Q30442808-75E06574-6B75-4D1C-8FA6-DF7B8CD6BA34

P2093

Q30442808-4851B704-1A93-4FE9-891C-1682FB5AF26F

Q30442808-4CB81DEA-0E92-4E58-97D9-8AF38F670EDC

Q30442808-61E70820-9556-4592-A86C-2466B8720BEC

Q30442808-6B80DB5E-CFC1-4EF8-B48D-3AC603FC7758

Q30442808-9130650F-A285-4AA0-9EDB-B4CDB276A672

Q30442808-999E5BC6-5ACB-40F9-8E92-0E0FD8A587DF

Q30442808-9CE99FA9-FD91-473B-A358-ECF5CE76432B

Q30442808-AC4DAA68-13EF-49BF-86BD-1F9326E01301

Q30442808-BC968751-5042-4122-95B1-329F4AC67C23

Q30442808-D2AD736A-6BC0-4945-AD19-BEFBF7A2D255

P2860

Q30442808-0389CA27-2A5D-4167-B2EE-26558DFBD904

Q30442808-15D9C8C0-885C-4D48-8E76-44C89244D615

Q30442808-1684FF65-226C-44C5-9B32-18B4836CC362

Q30442808-181564E5-55F0-46D4-A276-BDE3FC726F54

Q30442808-206B9FA0-F6E1-412D-8EC3-54B5B1041B1C

Q30442808-20D98440-ADD5-438B-AFF5-E2919B25EB27

Q30442808-26106714-B280-48EA-921A-FBA47AE17E6C

Q30442808-292294BD-9660-4DD7-83E4-E2B211B5294F

Q30442808-3CA6B2ED-B9C7-41FC-96E1-6DAB4F9BED8C

Q30442808-42251416-6ECA-4A60-88E2-3B5BD483E058

P304

Q30442808-A79277AA-5751-4337-A908-CEE7BC42EDEE

P31

Q30442808-A0B2F1CE-8F84-436D-8C5A-64EF425FD84E

P356

Q30442808-230958F7-8415-4F7A-9922-4EF6E89E35DF

P407

Q30442808-FEDAB05A-2FED-468D-9975-1D2A34951D01

P433

Q30442808-FDE4EEEB-0332-4172-9162-13DAE244E029

P478

Q30442808-8493F889-6883-440A-87B2-88D88298A398

P577

Q30442808-11949FA7-7966-48CF-BF93-A9ED6F90F184

P5875

Q30442808-40CB2D66-3FE0-4BBD-AF80-489E4CA6CCD3

P698

Q30442808-8686DCC6-8DAD-4301-A2FA-15715667DED0

P932

Q30442808-75146506-EBD9-4189-BCDC-E0078941D1B2

P356

P1433

Journal of Experimental Medicine

P1476

Biochemical identification of ...... recognized by CD4(+) T cells.

@en

P2093

Christian RE

http://www.w3.org/2001/XMLSchema#string

Gonzales MI

http://www.w3.org/2001/XMLSchema#string

Gupta G

http://www.w3.org/2001/XMLSchema#string

Hunt DF

http://www.w3.org/2001/XMLSchema#string

Nishimura MI

http://www.w3.org/2001/XMLSchema#string

Pieper R

http://www.w3.org/2001/XMLSchema#string

Rosenberg SA

http://www.w3.org/2001/XMLSchema#string

Settlage RE

http://www.w3.org/2001/XMLSchema#string

Shabanowitz J

http://www.w3.org/2001/XMLSchema#string

Topalian SL

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Two-dimensional electrophoretic analysis of human breast carcinoma proteins: mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2

Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

A two-dimensional gel database of human colon carcinoma proteins

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

A unique tumor antigen produced by a single amino acid substitution

Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database

Human triosephosphate isomerase: substitution of Arg for Gly at position 122 in a thermolabile electromorph variant, TPI-Manchester.

P304

757-766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.189.5.757

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13240265

http://www.w3.org/2001/XMLSchema#string

P698

10049939

http://www.w3.org/2001/XMLSchema#string

P932

2192954

http://www.w3.org/2001/XMLSchema#string